Method for isolating pharmaceutically exploitable etidronate disodium

Details for Australian Patent Application No. 2002223449 (hide)

Owner Schering AG

Inventors Rathe, Harald; Grawe, Detlef; Schmidt, Barbara

Agent Davies Collison Cave

Pub. Number AU-B-2002223449

PCT Pub. Number WO02/26751

Priority 10049735 28.09.00 DE

Filing date 28 September 2001

Wipo publication date 8 April 2002

Acceptance publication date 22 March 2007

International Classifications

C07F 9/38 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

22 March 2007 Application Accepted

  Published as AU-B-2002223449

19 July 2007 Standard Patent Sealed

23 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002223450-Method for generating or increasing resistance to biotic or abiotic stress factors in organisms

2002223448